ERBB2 and breast carcinoma: Although most types of breast cancer express hormone receptors (HR), there is a distinct subtype called triple-negative breast cancer (TNBC) that lacks the immunohistochemical expression of oestrogen receptor (ER), progesterone receptor (PR) and the HER2/neu protein or amplification of the HER2/neu gene.